The effects of obesity and weight loss in heart failure, imaging the obesity paradox using magnetic resonance imaging and spectroscopy (Dr Jenny Rayner)
Description: Although obesity is a powerful risk factor for the development of heart failure, obesity itself is associated with better survival in established heart failure. The reasons for this "obesity paradox" are not well understood. In addition, whilst weight loss is associated with beneficial reverse cardiac remodeling and improved survival in obesity without heart failure, its effect in obese subjects with heart failure is unknown. However, given the high prevalence of obese subjects with heart failure and the lack of evidence whether to recommend weight loss in this setting, this is of major clinical importance. This project will use a combination of cardiopulmonary exercise testing, skeletal muscle testing and multi-parametric magnetic resonance imaging and spectroscopy to; 1) investigate any differences in cardiovascular structure, function, rest and stress myocardial high energy phosphate metabolism, steatosis, extracellular volume fraction and skeletal muscle function between normal weight and obese subjects with heart failure, to explain the obesity paradox and 2) compare the cardiovascular and skeletal muscle benefits achieved with weight loss in obese subjects with normal systolic function to those with established systolic heart failure. This study should provide important insights into the mechanism of the obesity paradox, and clarify what advise should be given to obese heart failure patients with respect to weight loss.
Funder: British Heart Foundation
Amount: £306,400
Funding type: fellowship
Funder scheme: Fellowship
Start date: 2014-11-01
End date: 2018-08-31
Investigator: Oliver Rider (lead)
Institution: University of Oxford
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Funded outputs count: 16
Funder award ID: FS/14/54/30946
OpenAlex ID: G7996764079
